首页> 美国卫生研究院文献>The British Journal of Venereal Diseases >Is antenatal syphilis screening still cost effective in sub-Saharan Africa
【2h】

Is antenatal syphilis screening still cost effective in sub-Saharan Africa

机译:在撒哈拉以南非洲产前梅毒筛查是否仍具有成本效益?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objectives: To estimate the cost effectiveness of on-site antenatal syphilis screening and treatment in Mwanza, Tanzania. To compare this intervention with other antenatal and child health interventions, specifically the prevention of mother to child transmission of HIV (PMTCT). >Methods: The economic costs of adding the intervention to routine antenatal care were assessed. Cost effectiveness (CE) ratios of the intervention were obtained for low birth weight (LBW) live births and stillbirths averted and cost per DALY saved. Cost per DALY saved was also estimated for previous CE studies of syphilis screening. The CE of the intervention at different syphilis prevalence rates was modelled. >Results: The economic cost of the intervention is $1.44 per woman screened, $20 per woman treated, and $187 per adverse birth outcome averted. The cost per DALY saved is $110 with LBW as the only adverse outcome. When including stillbirth, this estimate improves 10-fold to $10.56 per DALY saved. The cost per DALY saved from all syphilis screening studies ranged from $3.97 to $18.73. >Conclusions: Syphilis screening is shown to be at least as cost effective as PMTCT and more cost effective than many widely implemented interventions. There is urgent need for scaling up syphilis screening and treatment in high prevalence areas. The CE of screening interventions is highly dependent on disease prevalence. In combination, PMTCT and syphilis screening and treatment interventions may achieve economies of scope and thus improved efficiency.
机译:>目标:评估坦桑尼亚姆万扎现场产前梅毒筛查和治疗的成本效益。将该干预措施与其他产前和儿童健康干预措施进行比较,尤其是预防母婴传播艾滋病毒(PMTCT)。 >方法:评估了将干预措施添加到常规产前护理的经济成本。对于低出生体重(LBW)活产婴儿和避免死产的患者,获得了干预措施的成本效益(CE)比率,并且每个DALY节省了成本。先前对梅毒筛查的CE研究也估计了每DALY节省的成本。对不同梅毒患病率的干预措施的CE进行了建模。 >结果:该干预措施的经济成本为每位接受筛查的妇女1.44美元,每位接受治疗的妇女20美元,避免每例不利的分娩结果187美元。每个DALY节省的费用为110美元,其中LBW是唯一的不良结局。如果包括死产,则此估算将节省10倍,达到每个DALY节省$ 10.56。所有梅毒筛查研究每个DALY节省的费用从3.97美元到18.73美元不等。 >结论:梅毒筛查被证明至少与PMTCT一样具有成本效益,并且比许多广泛实施的干预措施更具成本效益。迫切需要在高流行地区扩大梅毒的筛查和治疗。筛查干预措施的CE高度依赖于疾病患病率。结合使用PMTCT和梅毒筛查和治疗干预措施可以实现范围经济,从而提高效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号